Drug Name and FDA Application Number | Dosage Form/Route | Strength | Marketing Status | Company |
ACETAMINOPHEN
(NDA # 018337)
| SUPPOSITORY; RECTAL |
650MG 325MG 120MG
|
OTC
| ACTAVIS MID ATLANTIC |
ACETAMINOPHEN
(ANDA # 070607)
| SUPPOSITORY; RECTAL |
120MG
|
OTC
| SUPPOSITORIA |
ACETAMINOPHEN
(ANDA # 070608)
| SUPPOSITORY; RECTAL |
650MG
|
OTC
| SUPPOSITORIA |
ACETAMINOPHEN
(ANDA # 071010)
| SUPPOSITORY; RECTAL |
120MG
|
Discontinued
| ROXANE |
ACETAMINOPHEN
(ANDA # 071011)
| SUPPOSITORY; RECTAL |
650MG
|
Discontinued
| ROXANE |
ACETAMINOPHEN
(ANDA # 073106)
| SUPPOSITORY; RECTAL |
120MG
|
Discontinued
| ABLE |
ACETAMINOPHEN
(ANDA # 073107)
| SUPPOSITORY; RECTAL |
325MG
|
Discontinued
| ABLE |
ACETAMINOPHEN
(ANDA # 073108)
| SUPPOSITORY; RECTAL |
650MG
|
Discontinued
| ABLE |
ACETAMINOPHEN
(ANDA # 075077)
| TABLET, EXTENDED RELEASE; ORAL |
650MG
|
OTC
| PERRIGO |
ACETAMINOPHEN
(ANDA # 076200)
| TABLET, EXTENDED RELEASE; ORAL |
650MG
|
OTC
| COREPHARMA |